Xenon: Elemental anaesthesia in clinical practice

British Medical Bulletin

Volumn 71, Issue , 2004, Pages 115-135

  Sanders, Robert D ^a,b   Ma, Daqing ^a   Maze, Mervyn ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; DIZOCILPINE; ISOFLURANE; SEDATIVE AGENT; XENON;

ANALGESIA; ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CARDIOVASCULAR EFFECT; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG METABOLISM; DRUG STABILITY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; MYOCARDIAL DEPRESSION; MYOCARDIAL DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; REVIEW; SAFETY;

ANALGESICS; ANESTHESIA; ANESTHESIA, CLOSED-CIRCUIT; ANESTHETICS; ANIMALS; CARDIOVASCULAR SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; RECEPTORS, AMINO ACID; XENON;

EID: 16444368592     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/ldh034     Document Type: Review

References (94)

1. Ball WC Jr, Stewart PB, Newsham LG, Bates DV (1962) Regional pulmonary function studied with xenon 133. J. Clin. Invest., 41, 519-31.
2. Cullen, SC, Gross EG (1951) The anaesthetic properties of xenon in animals and human beings, with additional observations on krypton. It Science, 113, 580-2.
3. Franks NP, Lieb WR (1994) Molecular and cellular mechanisms of general anaesthesia. Nature, 367, 607-14.
4. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR (1998) How does xenon produce anaesthesia? Nature, 396, 324.
5. De Sousa SL, Dickinson R, Lieb WR, Franks NP (2000) Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. Anesthesiology, 92, 1055-66.
6. Plested AJ, Wildman SS, Lieb WR, Franks NP (2004) Determinants of the sensitivity of AMPA receptors to xenon. Anesthesiology, 100, 347-58.
7. Jevtovic-Todorovic V, Todorovic SM, Mennerick S et al. (1998) Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med., 4, 460-3.
8. Raines DE, Claycomb RJ, Scheller M, Forman SA (2001) Nonhalogenated alkane anesthetics fail to potentiate agonist actions on two ligand-gated ion channels. Anesthesiology, 95, 470-7.
9. Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J. Pharmacol., 79, 565-75.
10. + channels. Nat. Neurosci., 2, 422-6.
11. Patel AJ, Honore E (2001) Properties and modulation of mammalian 2P domain K+ channels. Trends Neurosci., 24, 339-46.
12. + channels. Anesthesiology, 95, 1013-21.
13. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol. Pharmacol., 65, 443-52.
14. Rossaint R, Reyle-Hahn M, Schulte AM et al.: Xenon Study Group (2003) Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology, 98, 6-13.
15. Bedi A, Murray JM, Dingley J, Stevenson MA, Fee JP (2003) Use of xenon as a sedative for patients receiving critical care. Crit. Care Med., 31, 2470-7.
16. Cullen SC, Eger EI, Cullen BF, Gregory P (1969) Observations on the anesthetic effect of the combination of xenon and halothane. Anesthesiology, 31, 305-9
17. Nakata Y, Goto T, Ishiguro Y et al. (2001) Minimum alveolar concentration (MAC) of xenon with sevoflurane in humans. Anesthesiology, 94, 611-14.
18. Goto T, Nakata Y, Morita S (2002) The minimum alveolar concentration of xenon in the elderly is sex-dependent. Anesthesiology, 97, 1129-32.
19. Stanski DR (2000) Monitoring depth of anesthesia. In Miller RD (ed.) Anesthesia. Philadelphia, PA: Churchill Livingstone, 1087-116.
20. Goto T, Nakata Y, Ishiguro Y, Niimi Y, Suwa K, Morita S (2000) Minimum alveolar concentration-awake of xenon alone and in combination with isoflurane or sevoflurane. Anesthesiology, 93, 1188-93.
21. Thornton C, Barrowcliffe MP, Konieczko KM et al. (1989) The auditory evoked response as an indicator of awareness. Br. J. Anaesth., 63, 113-15.
22. Newton DE, Thornton C, Konieczko KM et al. (1992) Auditory evoked response and awareness: a study in volunteers at sub-MAC concentrations of isoflurane. Br. J. Anaesth., 69, 122-9.
23. Rampil IJ (1998) A primer for EEG signal processing in anesthesia. Anesthesiology, 89, 980-1002.
24. Goto T, Nakata Y, Saito H et al. (2000) Bispectral analysis of the electroencephalogram does not predict responsiveness to verbal command in patients emerging from xenon anaesthesia. Br. J. Anaesth., 85, 359-63.
25. Goto T, Nakata Y, Saito H, Ishiguro Y, Niimi Y, Morita S (2001) The midlatency auditory evoked potentials predict responsiveness to verbal commands in patients emerging from anesthesia with xenon, isoflurane, and sevoflurane but not with nitrous oxide. Anesthesiology, 94, 782-9.
26. Sal'nikov PS, Burov NE. (2003) Electrophysiological features of xenon anesthesia. Anesteziol. Reanimatol., 1, 12-17 (in Russian).
27. Nakata Y, Goto T, Morita S (1997) Comparison of inhalation inductions with xenon and sevoflurane. Acta Anaesthesiol. Scand., 41, 1157-61.
28. Goto T, Saito H, Shinkai M, Nakata Y, Ichinose F, Morita S (1997) Xenon provides faster emergence from anesthesia than does nitrous oxide-sevoflurane or nitrous oxide-isoflurane. Anesthesiology, 86, 1273-8.
29. Dingley J, King R, Hughes L et al. (2001) Exploration of xenon as a potential cardiostable sedative: a comparison with propofol after cardiac surgery. Anaesthesia, 56, 829-35.
30. Goto T, Suwa K, Uezono S, Ichinose F, Uchiyama M, Morita S. (1998) The blood-gas partition coefficient of xenon may be lower than generally accepted. Br. J. Anaesth., 80, 255-6.
31. Cheng DC, Karski J, Peniston C et al. (1996) Early tracheal extubation after coronary artery bypass graft surgery reduces costs and improves resource use. A prospective, randomized, controlled trial. Anesthesiology, 85, 1300-10.
32. Lachmann B, Armbruster S, Schairer W et al. (1990) Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet, 335, 1413-15.
33. Boomsma F, Rupreht J, Man in 't Veld AJ, de Jong FH, Dzoljic M, Lachmann B (1990) Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide. Anaesthesia, 45, 273-8.
34. Luttropp HH, Romner B, Perhag L, Eskilsson J, Fredriksen S, Werner O (1993) Left ventricular performance and cerebral haemodynamics during xenon anaesthesia. A transoesophageal echocardiography and transcranial Doppler sonography study. Anaesthesia, 48, 1045-9.
35. Ishiguro Y, Goto T, Nakata Y, Terui K, Niimi Y, Morita S (2000) Effect of xenon on autonomic cardiovascular control-comparison with isoflurane and nitrous oxide. J. Clin. Anesth., 12, 196-201.
36. Ishiguro, Y (2001) Cardiovascular effects of xenon. Int. Anesthesiol. Clin., 39, 77-84.
37. Preckel B, Schlack W, Heibel T, Rutten H (2002) Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function. Br. J. Anaesth., 88, 264-9.
38. Hettrick DA, Pagel PS, Kersten JR et al. (1998) Cardiovascular effects of xenon in isoflurane-anesthetized dogs with dilated cardiomyopathy. Anesthesiology, 89, 1166-73.
39. Preckel B, Mullenheim J, Moloschavij A, Thamer V, Schlack W (2000) Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth. Analg., 91, 1327-32.
40. Stowe DF, Rehmert GC, Kwok WM, Weigt HU, Georgieff M, Bosnjak ZJ (2000) Xenon does not alter cardiac function or major cation currents in isolated guinea pig hearts or myocytes. Anesthesiology, 92, 516-22.
41. Fassl J, Halaszovich CR, Huneke R, Jungling E, Rossaint R, Luckhoff A (2003) Effects of inhalational anesthetics on L-type Ca2+ currents in human atrial cardiomyocytes during beta-adrenergic stimulation. Anesthesiology, 99, 90-6.
42. Stowe DF, Monroe SM, Marijic J, Bosnjak ZJ, Kampine JP (1991) Comparison of halothane, enflurane, and isoflurane with nitrous oxide on contractility and oxygen supply and demand in isolated hearts. Anesthesiology, 75, 1062-7.
43. Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med., 330, 613-22.
44. Sattler R, Tymianski M (2000) Molecular mechanisms of calcium-dependent excitotoxicity. J. Mol. Med., 78, 3-13.
45. Hardingham GE, Bading H (2003) The yin and yang of NMDA receptor signalling. Trends Neurosci., 26, 81-9.
46. Wilhelm S, Ma D, Maze M, Franks NP (2002) Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology, 96, 1485-91.
47. Petzelt C, Blom P, Schmehl W, Muller J, Kox WJ (2003) Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci., 72, 1909-18.
48. Hardingham GE, Fukunaga Y, Bading H (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci., 5, 405-14.
49. Miura Y, Grocott HP, Bart RD, Pearlstein RD, Dexter F, Warner DS (1998) Differential effects of anesthetic agents on outcome from near-complete but not incomplete global ischemia in the rat. Anesthesiology, 89, 391-400.
50. Ma D, Hossain M, Rajakumaraswamy N, Franks NP, Maze M (2003) Combination of xenon and isoflurane produces a synergistic protective effect against oxygen-glucose deprivation injury in a neuronal-glial co-culture model. Anesthesiology, 99, 748-51.
51. Homi HM, Yokoo N, Ma D et al. (2003) The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology, 99, 876-81.
52. Ma D, Yang H, Lynch J, Franks NP, Maze M, Grocott HP (2003) Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 98, 690-8.
53. David HN, Leveille F, Chazalviel L et al. (2003) Reduction of ischemic brain damage by nitrous oxide and xenon. J. Cereb. Blood Flow Metab., 23, 1168-73.
54. Yamaguchi S, Midorikawa Y, Okuda Y, Kitajima T. (1999) Propofol prevents delayed neuronal death following transient forebrain ischemia in gerbils. Can. J. Anaesth., 46, 593-8.
55. Pittman JE, Sheng H, Pearlstein R, Brinkhous A, Dexter F, Warner DS (1997) Comparison of the effects of propofol and pentobarbital on neurologic outcome and cerebral infarct size after temporary focal ischemia in the rat. Anesthesiology, 87, 1139-44.
56. Malhotra AK, Pinals DA, Weingartner H et al. (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology, 14, 301-7.
57. Lees KR (1997) Cerestat and other NMDA antagonists in ischemic stroke. Neurology, 49, S66-9.
58. Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science, 244, 1360-2.
59. Allen HL, Iversen LL (1990) Phencyclidine, dizocilpine, and cerebrocortical neurons. Science, 247, 221.
60. Ma D, Wilhelm S, Maze M, Franks NP (2002) Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br. J. Anaesth., 89, 739-46.
61. 2O enhances ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices. Anesth. Analg., 92, 362-8.
62. Wang S, Yang Q, Moller CJ, Sharp FR, Haglid KG (1996) Eliprodil prevents expression of the 70 kDa heat shock protein in MK801-injured neurones. Pharmacol. Toxicol., 79, 166-8.
63. Duprat F, Lesage F, Patel AJ, Fink M, Romey G, Lazdunski M (2000) The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK. Mol. Pharmacol., 57, 906-12.
64. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M (2000) Polyunsaturated fatty acids are potent neuroprotectors. EMBO J., 19, 1784-93.
65. Frietsch T, Bogdanski R, Blobner M, Werner C, Kuschinsky W, Waschke KF (2001) Effects of xenon on cerebral blood flow and cerebral glucose utilization in rats. Anesthesiology, 94, 290-7.
66. Hartmann A, Wassman H, Czernicki Z, Dettmers C, Schumacher HW, Tsuda Y (1987) Effect of stable xenon in room air on regional cerebral blood flow and electroencephalogram in normal baboons. Stroke, 18, 643-8.
67. Schmidt M, Marx T, Kotzerke J et al. (2001) Cerebral and regional organ perfusion in pigs during xenon anaesthesia. Anaesthesia, 56, 1154-9.
68. Lewett W, Williams C, Gupta A, Hummel R, Keenan R (1996) Effect of 70% xenon on cerebral blood flow velocity in anaesthetized patients. Acta Neurol. Scand., 166, 42-3.
69. Fukuda T, Nakayama H, Yanagi K et al. (2001) The effects of 30% and 60% xenon inhalation on pial vessel diameter and intracranial pressure in rabbits. Anesth. Analg., 92, 1245-50.
70. Plougmann J, Astrup J, Pedersen J, Gyldensted C (1994) Effect of stable xenon inhalation on intracranial pressure during measurement of cerebral blood flow in head injury. J. Neurosurg., 81, 822-8.
71. Nakata Y, Goto T, Saito H et al. (2000) Plasma concentration of fentanyl with xenon to block somatic and hemodynamic responses to surgical incision. Anesthesiology, 92, 1043-8.
72. Yagi M, Mashimo T, Kawaguchi T, Yoshiya I (1995) Analgesic and hypnotic effects of subanaesthetic concentrations of xenon in human volunteers: comparison with nitrous oxide. Br. J. Anaesth., 74, 670-3.
73. Fujinaga M, Maze M (2002) Neurobiology of nitrous oxide-induced antinociceptive effects. Mol. Neurobiol., 25, 167-89.
74. Ohara A, Mashimo T, Zhang P, Inagaki Y, Shibuta S, Yoshiya I (1997) A comparative study of the antinociceptive action of xenon and nitrous oxide in rats. Anesth. Analg., 85, 931-6.
75. Miyazaki, Y, Adachi T, Utsumi J, Shichino T, Segawa H (1999) Xenon has greater inhibitory effects on spinal dorsal horn neurons than nitrous oxide in spinal cord transected cats. Anesth. Analg., 88, 893-7.
76. Ohashi Y, Stowell JM, Nelson LE, Hashimoto T, Maze M, Fujinaga M (2002) Nitrous oxide exerts age-dependent antinociceptive effects in Fischer rats. Pain, 100, 7-18.
77. Ma D, Sanders RD, Halder S, Rajakumaraswamy N, Franks NP, Maze M (2004) Xenon exhibits antinociceptive effect on the formalin test in newborn Fischer rats. Anesthesiology, 100, 1313-18.
78. Baum VC, Palmisano BW (1997) The immature heart and anesthesia. Anesthesiology, 87, 1529-48.
79. Horn NA, Hecker KE, Bongers B, Baumert HJ, Reyle-Hahn SM, Rossaint R (2001) Coagulation assessment in healthy pigs undergoing single xenon anaesthesia and combinations with isoflurane and sevoflurane. Acta Anaesthesiol. Scand., 45, 634-8.
80. de Rossi LW, Horn NA, Baumert JH, Gutensohn K, Hutschenreuter G, Rossaint R (2001) Xenon does not affect human platelet function in vitro. Anesth. Analg., 93, 635-40.
81. Bedi A, McBride WT, Armstrong MA, Murray JM, Fee JP (2002) Xenon has no effect on cytokine balance and adhesion molecule expression within an isolated cardiopulmonary bypass system. Br. J. Anaesth., 89, 546-50.
82. Reinelt H, Marx T, Kotzerke J et al. (2002) Hepatic function during xenon anesthesia in pigs. Acta Anaesthesiol. Scand., 46, 713-16.
83. Avdeev SV, Pak AV, Strezh VA (2002) Liver blood flow during xenon anesthesia in surgical hepatology. Anesteziol. Reanimatol., 3, 27-31 (in Russian).
84. Calzia E, Stahl W, Handschuh T, Marx T et al. (1999) Respiratory mechanics during xenon anesthesia in pigs: comparison with nitrous oxide. Anesthesiology, 91, 1378-86.
85. Zhang P, Ohara A, Mashimo T, Imanaka H, Uchiyama A, Yoshiya I (1995) Pulmonary resistance in dogs: a comparison of xenon with nitrous oxide. Can. J. Anaesth., 42, 547-53.
86. Baumert JH, Reyle-Hahn M, Hecker K, Tenbrinck R, Kuhlen R, Rossaint R (2002) Increased airway resistance during xenon anaesthesia in pigs is attributed to physical properties of the gas. Br. J. Anaesth., 88, 540-5.
87. 2) measurements in swine during nitrous oxide and xenon elimination: prevention of diffusion hypoxia. Anesthesiology, 90, 829-34.
88. Baur CP, Klingler W, Jurkat-Rott K et al. (2000) Xenon does not induce contracture in human malignant hyperthermia muscle. Br. J. Anaesth., 85, 712-16.
89. Froeba G, Marx T, Pazhur J et al. (1999) Xenon does not trigger malignant hyperthermia in susceptible swine. Anesthesiology, 91, 1047-52.
90. Burov NE, Kornienko LI, Makeev GN, Potapov VN (1999) Clinical and experimental study of xenon anesthesia]. Anesteziol. Reanimatol., 56-60 (in Russian).
91. Lynch C, III, Baum J, Tenbrinck R (2000) Xenon anesthesia. Anesthesiology, 92, 865-8.
92. Nakata Y, Goto T, Niimi Y, Morita S (1999) Cost analysis of xenon anesthesia: a comparison with nitrous oxide-isoflurane and nitrous oxide-sevoflurane anesthesia. J. Clin. Anesth., 11, 477-81.
93. Luginbuhl M, Lauber R, Feigenwinter P, Zbinden AM (2002) Monitoring xenon in the breathing circuit with a thermal conductivity sensor. Comparison with a mass spectrometer and implications on monitoring other gases. J. Clin. Monit. Comput., 17, 23-30.
94. Goto T. Is there a future for xenon anesthesia?/Le xenon a-t-il un avenir en anesthesie? Can. J. Anaesth., 49, 335-8.